Karen AddingtonSector leader
chief executive of the diabetes charity Breakthrough T1D
Cited in UK press coverage of health & social care
1 citation
Across 1 topic, first on 27 Aug 2026.
Expertise
Cited on
What they’ve said
“For the first time, we have an immunotherapy that can delay the onset of symptomatic type 1 diabetes. If it were your child or someone you love, you would want to do everything possible to give them more years without the daily burden of managing this relentless condition.”
chief executive of the diabetes charity Breakthrough T1D · Hospital discharge / bed-blocking · 27 Aug 2026 · Drug that delays onset of type 1 diabetes approved in England and Wales ↗
Source references
- Drug that delays onset of type 1 diabetes approved in England and Walestheguardian.com · 27 Aug 2026
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.